EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

m 6 A‐modified DRAM1 recognized by YTHDF1 regulates autophagy during dexamethasone‐induced osteogenic inhibition

Ze-Yu Lu iD, Peng-Bo Chen iD, Qing-Yin Xu iD, Muradil Mardan iD, Yue-Hua Yang, Tao Liu iD, Wen-Ning Xu iD, Huo-Liang Zheng iD, Hao Cai, Hui Deng iD, Xing-Xu Huang iD, Bo Li iD und 3 weitere

Clinical and Translational Medicine · 2026-07 · 16 (7)

DOI: 10.1002/ctm2.70655 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 22.07.2026. Verfasst von Ze-Yu Lu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Spine Center, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Dexamethasone, Osteogenesis, Autophagy, RNA-Binding Proteins. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone health is critically dependent on the precise regulation of bone‐forming cells, which are significantly impacted by glucocorticoids. Although DNA damage‐regulated autophagy modulator 1 (DRAM1) plays a key role in autophagy, its involvement in glucocorticoid‐induced osteoporosis has not been fully explored. Here, we showed that alterations in N 6 ‐methyladenosine (m 6 A) levels contributed to the regulation of DRAM1 under dexamethasone treatment. In vitro, our research revealed that high doses of dexamethasone impaired the m 6 A‐dependent regulation of DRAM1 by YTH m 6 A RNA binding protein F1 (YTHDF1), leading to decreased DRAM1 levels and subsequent disruption of autophagy‐associated osteogenic differentiation in human bone marrow mesenchymal stem cells (hBMSCs) and MC3T3‐E1 cells. Additionally, the classic Wnt/β‐catenin pathway, which plays a critical role in bone formation, was shown to be modulated by DRAM1 during osteogenic differentiation. In vivo experiments showed that DRAM1 protein expression in the femurs of Ythdf1 knockout (KO) mice was significantly lower than that in the wild‐type (WT) group, and that resveratrol not only mitigated dexamethasone‐induced bone damage but was also associated with increased DRAM1 expression. These findings advance our understanding of how glucocorticoids hinder bone formation and suggest that targeting the m 6 A‐dependent YTHDF1/DRAM1 regulatory axis may offer novel strategies for osteoporosis treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexamethasoneOsteogenesisAutophagyRNA-Binding ProteinsAdenosineMembrane ProteinsAnimalsMiceHumansMesenchymal Stem CellsCell DifferentiationMice, KnockoutGlucocorticoids

Stichwörter der Autor:innen

N6‐methyladenosineWnt/β‐catenin signallingautophagydexamethasoneosteogenic differentiation

Substanzen

DexamethasoneRNA-Binding ProteinsYthdf1 protein, mouseAdenosineN-methyladenosineMembrane ProteinsGlucocorticoids

Autor:innen und Institutionen

  • Spine Center, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Orthopedic Surgery, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
  • Department of Orthopedic Surgery, The Affiliated People's Hospital of Jiangsu University, Zhenjiang, China.
  • Department of Spinal Surgery, Orthopedic Medical Center, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • School of Life Science and Technology, ShanghaiTech University, Shanghai, China.

ORCID-Profile: Ze-Yu Lu, Peng-Bo Chen, Qing-Yin Xu, Muradil Mardan, Tao Liu, Wen-Ning Xu, Huo-Liang Zheng, Hui Deng, Xing-Xu Huang, Bo Li, Sheng-Dan Jiang, Lei-Sheng Jiang, Xin-Feng Zheng

Förderung

  • National Natural Science Foundation of China
  • Shanghai Municipal Health Commission

Zitieren

APA

Lu, Z. Y., Chen, P. B., Xu, Q. Y., Mardan, M., Yang, Y. H., Liu, T., Xu, W. N., Zheng, H. L., Cai, H., Deng, H., Huang, X. X., Li, B., Jiang, S. D., Jiang, L. S., & Zheng, X. F. (2026). m 6 A‐modified DRAM1 recognized by YTHDF1 regulates autophagy during dexamethasone‐induced osteogenic inhibition. Clinical and Translational Medicine, 16(7). https://doi.org/10.1002/ctm2.70655

Vancouver

Lu ZY, Chen PB, Xu QY, Mardan M, Yang YH, Liu T, et al. m 6 A‐modified DRAM1 recognized by YTHDF1 regulates autophagy during dexamethasone‐induced osteogenic inhibition. Clinical and Translational Medicine. 2026;16(7). doi:10.1002/ctm2.70655

BibTeX
@article{Lu2026,
  author = {Lu, Ze-Yu and Chen, Peng-Bo and Xu, Qing-Yin and Mardan, Muradil and Yang, Yue-Hua and Liu, Tao and Xu, Wen-Ning and Zheng, Huo-Liang and Cai, Hao and Deng, Hui and Huang, Xing-Xu and Li, Bo and Jiang, Sheng-Dan and Jiang, Lei-Sheng and Zheng, Xin-Feng},
  title = {m 6 A‐modified DRAM1 recognized by YTHDF1 regulates autophagy during dexamethasone‐induced osteogenic inhibition},
  journal = {Clinical and Translational Medicine},
  year = {2026},
  volume = {16},
  number = {7},
  doi = {10.1002/ctm2.70655}
}
Kostenlos starten →